• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一系列作为多药耐药调节剂的塔里夸德类似物的构效关系

Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.

作者信息

Globisch Christoph, Pajeva Ilza K, Wiese Michael

机构信息

Institute of Pharmacy, University of Bonn, Germany.

出版信息

Bioorg Med Chem. 2006 Mar 1;14(5):1588-98. doi: 10.1016/j.bmc.2005.10.058. Epub 2005 Nov 22.

DOI:10.1016/j.bmc.2005.10.058
PMID:16307883
Abstract

Tariquidar (XR9576) analogs, modulators of cancer multidrug resistance (MDR), were subjected to QSAR and 3D-QSAR analyses. The structural features contributing to anti-MDR activity were identified by the Free-Wilson analysis and pharmacophore search using Hoechst 33342 as a template. 3D-QSAR CoMFA and CoMSIA models were derived and tested. The best models yielded an external predictivity of 0.66-0.75 squared correlation coefficient and outlined HB-acceptor, steric, and hydrophobic fields as the most important 3D properties. On the basis of the QSAR and 3D-QSAR analyses it was suggested that the strong inhibitory potency of the compounds studied is related to the presence of a bulky aromatic ring system with a 3rd positioned heteroatom toward the anthranilamide nucleus in the opposite end of the tetrahydroquinoline group. The results can help in directing the rational design of new generations of potent P-glycoprotein MDR modulators.

摘要

他立喹达(XR9576)类似物,即癌症多药耐药性(MDR)调节剂,进行了定量构效关系(QSAR)和三维定量构效关系(3D-QSAR)分析。通过自由威尔逊分析和以Hoechst 33342为模板的药效团搜索,确定了有助于抗MDR活性的结构特征。推导并测试了3D-QSAR比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)模型。最佳模型的外部预测性相关系数平方为0.66 - 0.75,并勾勒出氢键受体、立体和疏水场是最重要的三维性质。基于QSAR和3D-QSAR分析,表明所研究化合物的强抑制效力与在四氢喹啉基团另一端朝向邻氨基苯甲酰胺核的位置3带有杂原子的庞大芳香环系统的存在有关。这些结果有助于指导新一代强效P-糖蛋白MDR调节剂的合理设计。

相似文献

1
Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.一系列作为多药耐药调节剂的塔里夸德类似物的构效关系
Bioorg Med Chem. 2006 Mar 1;14(5):1588-98. doi: 10.1016/j.bmc.2005.10.058. Epub 2005 Nov 22.
2
Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity.普罗帕酮类多药耐药调节剂的三维定量构效关系分析:变量选择对测试集预测能力的影响。
J Med Chem. 2003 Nov 6;46(23):4988-5004. doi: 10.1021/jm030876r.
3
A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.作为多药耐药调节剂的邻氨基苯甲酰胺衍生物的比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)
J Med Chem. 2006 Dec 28;49(26):7646-60. doi: 10.1021/jm060239b.
4
Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors.新型第三代P-糖蛋白抑制剂的功能测定及构效关系
Bioorg Med Chem. 2008 Mar 1;16(5):2448-62. doi: 10.1016/j.bmc.2007.11.057. Epub 2007 Nov 28.
5
Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.基于喹啉衍生物的 P-选择素抑制剂的三维定量构效关系建模和分子对接研究。
Chem Biol Drug Des. 2009 Dec;74(6):596-610. doi: 10.1111/j.1747-0285.2009.00893.x. Epub 2009 Oct 20.
6
Molecular modeling of triazine type MDR modulators using CoMFA and CoMSIA approaches.
SAR QSAR Environ Res. 2002 May-Jun;13(3-4):487-98. doi: 10.1080/10629360290002721.
7
Biological evaluation, structure-activity relationships, and three-dimensional quantitative structure-activity relationship studies of dihydro-beta-agarofuran sesquiterpenes as modulators of P-glycoprotein-dependent multidrug resistance.作为P-糖蛋白依赖性多药耐药调节剂的二氢-β-agarofuran倍半萜的生物学评价、构效关系及三维定量构效关系研究
J Med Chem. 2007 Oct 4;50(20):4808-17. doi: 10.1021/jm070290v. Epub 2007 Sep 12.
8
Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.第三代多药耐药调节剂小分子文库的合成与生物学评价
Bioorg Med Chem. 2009 Mar 15;17(6):2524-35. doi: 10.1016/j.bmc.2009.01.072. Epub 2009 Feb 5.
9
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.塔里喹达(XR9576):一种P-糖蛋白药物外排泵抑制剂。
Expert Rev Anticancer Ther. 2007 Apr;7(4):447-59. doi: 10.1586/14737140.7.4.447.
10
Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.吖啶酮可规避癌细胞中与P-糖蛋白相关的多药耐药性(MDR)。
Bioorg Med Chem. 2008 Jan 1;16(1):474-87. doi: 10.1016/j.bmc.2007.09.020. Epub 2007 Sep 15.

引用本文的文献

1
Ligand- and Structure-based Approaches for Transmembrane Transporter Modeling.基于配体和结构的跨膜转运体建模方法。
Curr Drug Res Rev. 2024;16(2):81-93. doi: 10.2174/2589977515666230508123041.
2
The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers.作为多药耐药性(MDR)逆转剂的ABC转运蛋白抑制剂中的四氢异喹啉支架结构
Curr Top Med Chem. 2022;22(31):2535-2569. doi: 10.2174/1568026623666221025111528.
3
TM2, a novel semi-synthetic taxoid, exerts anti-MDR activity in NSCLC by inhibiting P-gp function and stabilizing microtubule polymerization.
TM2,一种新型半合成紫杉烷类化合物,通过抑制 P-糖蛋白功能和稳定微管聚合来发挥抗多药耐药性(MDR)活性。
Apoptosis. 2022 Dec;27(11-12):1015-1030. doi: 10.1007/s10495-022-01767-4. Epub 2022 Sep 15.
4
Prediction of P-glycoprotein inhibitors with machine learning classification models and 3D-RISM-KH theory based solvation energy descriptors.基于机器学习分类模型和 3D-RISM-KH 理论的溶剂化能量描述符预测 P-糖蛋白抑制剂。
J Comput Aided Mol Des. 2019 Nov;33(11):965-971. doi: 10.1007/s10822-019-00253-5. Epub 2019 Nov 19.
5
Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors.P-糖蛋白表达与内质网应激因子耐药性的相互作用。
Molecules. 2018 Feb 6;23(2):337. doi: 10.3390/molecules23020337.
6
HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.HZ08在体外和体内逆转P-糖蛋白介导的多药耐药性。
PLoS One. 2015 Feb 17;10(2):e0116886. doi: 10.1371/journal.pone.0116886. eCollection 2015.
7
In vivo imaging of multidrug resistance using a third generation MDR1 inhibitor.使用第三代多药耐药基因1(MDR1)抑制剂对多药耐药性进行体内成像。
Bioconjug Chem. 2014 Jun 18;25(6):1137-42. doi: 10.1021/bc500154c. Epub 2014 May 14.
8
Nanopreparations to overcome multidrug resistance in cancer.纳米制剂克服癌症的多药耐药性。
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1748-62. doi: 10.1016/j.addr.2013.08.004. Epub 2013 Aug 23.
9
In silico quantitative structure-activity relationship studies on P-gp modulators of tetrahydroisoquinoline-ethyl-phenylamine series.四氢异喹啉-乙基-苯胺系列P-糖蛋白调节剂的计算机辅助定量构效关系研究
BMC Struct Biol. 2011 Jan 26;11:5. doi: 10.1186/1472-6807-11-5.
10
Structure-activity relationships of tariquidar analogs as multidrug resistance modulators.塔里喹达类似物作为多药耐药调节剂的构效关系。
AAPS J. 2009 Sep;11(3):435-44. doi: 10.1208/s12248-009-9118-z. Epub 2009 Jun 6.